In Vivo Selection of Fluoroquinolone-Resistant Escherichia coli Isolates Expressing Plasmid-Mediated Quinolone Resistance and Expanded-Spectrum β-Lactamase
Data(s) |
04/04/2014
04/04/2014
01/04/2006
|
---|---|
Resumo |
A ciprofloxacin-resistant Escherichia coli isolate, isolate 1B, was obtained from a urinary specimen of a Canadian patient treated with norfloxacin for infection due to a ciprofloxacin-susceptible isolate, isolate 1A. Both isolates harbored a plasmid-encoded sul1-type integron with qnrA1 and blaVEB-1 genes. Isolate 1B had amino acid substitutions in gyrase and topoisomerase. Journal Article; Research Support, Non-U.S. Gov't; This work was funded by a grant from the Ministére de l’Education Nationale et de la Recherche (UPRES-EA3539), Université Paris XI, France, and mostly by the European Community. INSERM, Paris, France. The Spanish Society for Clinical Microbiology and Infectious Diseases. |
Identificador |
Poirel L, Pitout JD, Calvo L, Rodriguez-Martinez JM, Church D, Nordmann P. In Vivo Selection of Fluoroquinolone-Resistant Escherichia coli Isolates Expressing Plasmid-Mediated Quinolone Resistance and Expanded-Spectrum β-Lactamase. [In vivo selection of fluoroquinolone-resistant Escherichia coli isolates expressing plasmid-mediated quinolone resistance and expanded-spectrum beta-lactamase]. Antimicrob. Agents Chemother. 2006; 50(4):1525-7 1098-6596 (Online) 0066-4804 (Print) PMC1426952 http://hdl.handle.net/10668/1570 16569874 10.1128/AAC.50.4.1525-1527.2006 |
Idioma(s) |
en |
Publicador |
American Society for Microbiology |
Relação |
Antimicrobial agents and chemotherapy http://aac.asm.org/content/50/4/1525.abstract |
Direitos |
Acceso abierto |
Palavras-Chave | #Escherichia coli #Plásmidos #Secuencia de Bases #Ciprofloxacino #Conjugación Genética #Farmacorresistencia Bacteriana #Fluoroquinolonas #Datos de Secuencia Molecular #beta-Lactamasas #Antiinfecciosos #Medical Subject Headings::Phenomena and Processes::Chemical Phenomena::Biochemical Phenomena::Molecular Structure::Base Sequence #Medical Subject Headings::Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 2-Ring::Quinolines::Quinolones::Fluoroquinolones::Ciprofloxacin #Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Processes::Recombination, Genetic::Conjugation, Genetic #Medical Subject Headings::Phenomena and Processes::Microbiological Phenomena::Bacterial Physiological Phenomena::Drug Resistance, Bacterial #Medical Subject Headings::Organisms::Bacteria::Gram-Negative Bacteria::Gram-Negative Facultatively Anaerobic Rods::Enterobacteriaceae::Escherichia::Escherichia coli #Medical Subject Headings::Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 2-Ring::Quinolines::Quinolones::Fluoroquinolones #Medical Subject Headings::Information Science::Information Science::Information Services::Documentation::Molecular Sequence Data #Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Structures::Plasmids #Medical Subject Headings::Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Hydrolases::Amidohydrolases::beta-Lactamases #Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Infective Agents, Urinary |
Tipo |
info:eu-repo/semantics/article info:eu-repo/semantics/published Artículo |